Go direct from plasma with Cell3TMDirect

Committed to providing end to end validated solutions for the use of cell free DNA in genetic testing

Innovative technologies including our new direct from plasma qPCR assays for NIPD RhD and fetal sexing testing

Focused on providing high quality products to the healthcare diagnostics sector

NONACUS’ FOCUS

As a company Nonacus is focused on delivering innovative technologies to the genomic healthcare sector. Founded by a team of scientists and sector professionals with experience in translating research into routine diagnostic tools that directly benefit patients. Nonacus provides end to end validated solutions for the use of cell free DNA in genetic testing.

Established in 2015 we have been actively perfecting and refining our processes for use in healthcare diagnostics.

Our innovative Cell3TMDirect qPCR technology allows direct from plasma testing. Providing a streamlined process to support non-invasive prenatal healthcare diagnostics.